Director, Strategic Planning & Operations
Amgen
Summary
The Director, Strategic Planning & Operations (SPO) for Amgen's Bone Health Business Unit (BHBU) will ensure the effective operation of the U.S. Bone Health business while leading strategic initiatives critical to its growth and evolution. The SPO will report directly to the VP/GM, BHBU, and work closely with the BHBU Leadership Team (LT), Marketing, Sales, and cross-functional partners, including Market Access, Medical, Finance, Business Insights, Patient Services, Regulatory, Supply, and Global colleagues.
Job description
Responsibilities Include
Strategic Planning and Operations Support
- Provide strategic and operational leadership for BHBU, ensuring effective planning, prioritization, and coordination across Marketing, Sales, and cross-functional partners.
- Partner with the VP/GM and BHBU LT to support decision-making, execution, and alignment on key business priorities.
- Lead and coordinate annual and long-range planning processes, ensuring alignment across strategic priorities, plans, and milestones.
- Manage the BHBU operating cadence and key forums, including LT meetings, business reviews, business-planning meetings, and town halls.
- Drive performance-management processes, including business reporting, insights, and action planning to enable timely decisions and course correction.
- Facilitate Marketing–Sales integration, ensuring alignment between brand strategy, field execution, customer insights, and commercial priorities.
- Develop key presentations, reports, and communications for governance meetings, leadership forums, and planning sessions.
- Interface with Global partners to support appropriate alignment and information sharing.
Leadership of Strategic Projects
- Lead cross-functional strategic projects that advance the BHBU commercial strategy, operating model, and long-term performance.
- Drive adoption of AI tools and capabilities to enhance business efficiency, analytics, and decision-making.
- Identify and execute opportunities to strengthen cross-functional integration, agility, and execution through innovation and best practices.
- Lead transformation initiatives that improve business processes, collaboration, and ways of working.
- Translate strategic priorities into integrated plans, clear accountabilities, and measurable outcomes.
- Anticipate emerging business needs and recommend solutions that improve planning and execution.
Requirements
- Master's degree and 7 years of project management experience; OR Bachelor's degree and 9 years of project management experience
- 4 years of leadership experience leading teams, projects, programs, or directing the allocation of resources
- Commercial biopharmaceutical experience, with demonstrated partnership across Marketing, Sales, and cross-functional teams
- Marketing experience, preferably at the Director level or with comparable strategic scope
- Experience in Bone Health, osteoporosis, or a relevant specialty therapeutic area
- Experience in sales leadership, launch excellence, lifecycle management, commercial planning, or performance management
- Experience in management consulting, strategic planning, or commercial operations is a plus
- Experience leading transformation initiatives and applying new tools, technologies, or operating models
- Ability to lead complex initiatives through influence in a matrixed environment
- Strong leadership, communication, stakeholder-management, and presentation skills
- Demonstrated creativity and foresight in anticipating and solving complex business issues
Benefits
- Retirement and Savings Plan
- Medical, Dental & Vision
- Life and Disability Insurance
- Flexible Spending Accounts
- Annual Bonus Program
- Stock-based Long-term Incentives
- Paid Time Off
- Bi-annual Company Shutdowns
- Flexible Work Models
Company overview
Amgen Inc. is a leading American multinational biopharmaceutical company headquartered in Thousand Oaks, California, founded in 1980. As one of the world's largest independent biotechnology companies, Amgen specializes in discovering, developing, manufacturing, and delivering innovative human therapeutics. The company focuses on six key therapeutic areas: inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience. Amgen's portfolio includes blockbuster drugs such as Enbrel for autoimmune diseases, Prolia and XGEVA for osteoporosis, Repatha for cholesterol management, Otezla for psoriasis, and Neulasta for chemotherapy-induced neutropenia. With approximately 28,000 employees worldwide, Amgen operates as a component of both the Dow Jones Industrial Average and Nasdaq-100 indices. The company maintains a robust research and development pipeline with numerous clinical programs across various stages, leveraging cutting-edge biotechnology and human genetic data to address some of the world's most challenging diseases. Amgen's manufacturing capabilities span multiple global locations, and it distributes products through pharmaceutical wholesale distributors and direct-to-consumer channels.